DK1400245T3 - Borsyresalte anvendelige til parenterale formuleringer til selektiv thrombininhibering - Google Patents
Borsyresalte anvendelige til parenterale formuleringer til selektiv thrombininhiberingInfo
- Publication number
- DK1400245T3 DK1400245T3 DK03255590T DK03255590T DK1400245T3 DK 1400245 T3 DK1400245 T3 DK 1400245T3 DK 03255590 T DK03255590 T DK 03255590T DK 03255590 T DK03255590 T DK 03255590T DK 1400245 T3 DK1400245 T3 DK 1400245T3
- Authority
- DK
- Denmark
- Prior art keywords
- boric acid
- acid salts
- parenteral formulations
- salts useful
- thrombin inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0220822A GB0220822D0 (en) | 2002-09-09 | 2002-09-09 | Boropeptides |
| GB0220764A GB0220764D0 (en) | 2002-09-09 | 2002-09-09 | Boropeptides |
| GB0307817A GB0307817D0 (en) | 2003-04-04 | 2003-04-04 | Boronic acid compounds |
| GB0311237A GB0311237D0 (en) | 2003-05-16 | 2003-05-16 | Boronic acid compounds |
| GB0315691A GB0315691D0 (en) | 2003-07-04 | 2003-07-04 | Boropeptides |
| US48578603P | 2003-07-08 | 2003-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1400245T3 true DK1400245T3 (da) | 2006-08-28 |
Family
ID=31721886
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03255590T DK1400245T3 (da) | 2002-09-09 | 2003-09-09 | Borsyresalte anvendelige til parenterale formuleringer til selektiv thrombininhibering |
| DK03255629T DK1396270T3 (da) | 2002-09-09 | 2003-09-09 | Borsyresalte |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03255629T DK1396270T3 (da) | 2002-09-09 | 2003-09-09 | Borsyresalte |
Country Status (20)
| Country | Link |
|---|---|
| EP (8) | EP1695711A3 (zh) |
| JP (3) | JP2006509034A (zh) |
| KR (2) | KR20050057294A (zh) |
| CN (2) | CN100553639C (zh) |
| AT (3) | ATE324899T1 (zh) |
| AU (3) | AU2003263328A1 (zh) |
| BR (1) | BR0314450A (zh) |
| CA (3) | CA2536010A1 (zh) |
| CY (1) | CY1105381T1 (zh) |
| DE (3) | DE60304956T2 (zh) |
| DK (2) | DK1400245T3 (zh) |
| ES (2) | ES2263924T3 (zh) |
| HK (1) | HK1063154A1 (zh) |
| IL (1) | IL167294A (zh) |
| MX (2) | MXPA05002661A (zh) |
| NZ (2) | NZ539333A (zh) |
| PL (2) | PL376535A1 (zh) |
| PT (1) | PT1396270E (zh) |
| SI (2) | SI1400245T1 (zh) |
| WO (3) | WO2004022072A1 (zh) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0405272D0 (en) * | 2004-03-09 | 2004-04-21 | Trigen Ltd | Compounds |
| GB0405280D0 (en) * | 2004-03-09 | 2004-04-21 | Trigen Ltd | Compounds |
| GB0405267D0 (en) * | 2004-03-09 | 2004-04-21 | Trigen Ltd | Compounds |
| AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
| WO2006059082A1 (en) * | 2004-11-30 | 2006-06-08 | Trigen Limited | Oxidised lipids as reversal agents for boronic acid drugs |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| GB0515003D0 (en) * | 2005-07-21 | 2005-08-31 | Univ Aston | Medical devices and coatings therefor |
| EP2190411A2 (en) * | 2007-08-21 | 2010-06-02 | Alza Corporation | Liposome compositions for in vivo administration of boronic acid compounds |
| CN101795672A (zh) * | 2007-08-21 | 2010-08-04 | 阿尔扎公司 | 硼酸化合物的脂质体制剂 |
| US8389232B2 (en) * | 2008-05-13 | 2013-03-05 | The Regents Of The University Of California | Fluorescence detection of poison oak oil |
| MX349769B (es) | 2008-06-17 | 2017-08-11 | Millennium Pharm Inc | Compuestos de éster boronato y composiciones farmacéuticas de los mismos. |
| US20120059036A1 (en) * | 2008-11-21 | 2012-03-08 | Marco Valgimigli | Method for reducing thrombocytopenia and thrombocytopenia-associated mortality |
| EP3021120A1 (en) | 2009-02-20 | 2016-05-18 | Michael P. Lisanti | Diagnosis, prognosis, therapeutics and methods for treating neoplastic deiseases comprising determining the level of caveolin-1 in a stromal cell sample |
| CN101928329B (zh) * | 2009-06-19 | 2013-07-17 | 北京大学 | 三肽硼酸(酯)类化合物、其制备方法和应用 |
| GB2523211B (en) | 2012-01-27 | 2020-03-18 | Univ Jefferson | MCT protein inhibitor-related prognostic and therapeutic methods |
| US10022372B2 (en) | 2013-04-19 | 2018-07-17 | Thomas Jefferson University | Caveolin-1 related methods for treating glioblastoma with temozolomide |
| KR102457840B1 (ko) * | 2014-10-01 | 2022-10-21 | 메르크 파텐트 게엠베하 | 보론산 유도체 |
| EP3472151A4 (en) | 2016-06-21 | 2020-03-04 | Orion Ophthalmology LLC | CARBOCYCLIC PROLINAMIDE DERIVATIVES |
| AU2017282651B2 (en) | 2016-06-21 | 2021-08-12 | Orion Ophthalmology LLC | Heterocyclic prolinamide derivatives |
| CN109187155B (zh) * | 2018-07-27 | 2021-08-13 | 临沂大学 | 一种水样中有效硼的提取纯化方法和一种硼同位素组成的测试方法 |
| KR102104507B1 (ko) * | 2019-08-23 | 2020-04-24 | 브릿지바이오테라퓨틱스(주) | 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법 |
| CN113121666B (zh) * | 2021-03-10 | 2023-09-12 | 厦门大学 | 抗菌肽Scybaumancin105-127及其应用 |
| CN114106346B (zh) * | 2021-10-29 | 2023-04-18 | 重庆第二师范学院 | 一种稀土双金属电致化学发光材料及其制备方法和应用 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5856695A (ja) | 1981-09-28 | 1983-04-04 | Nitto Boseki Co Ltd | 新規なトロンビン測定用基質 |
| US4499082A (en) | 1983-12-05 | 1985-02-12 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid peptides |
| US4935493A (en) | 1987-10-06 | 1990-06-19 | E. I. Du Pont De Nemours And Company | Protease inhibitors |
| EP0315574A3 (de) | 1987-11-05 | 1990-08-22 | Hoechst Aktiengesellschaft | Renin-Inhibitoren |
| US5574014A (en) | 1988-04-28 | 1996-11-12 | Thrombosis Research Institute | Inhibitors of trypsin-like enzymes |
| NZ229053A (en) | 1988-05-11 | 1990-12-21 | Du Pont | Pharmaceutical compositions comprising a protein or peptide and an alpha-aminoboronic acid derivative to stabilise and improve the delivery of the protein or peptide |
| US5106948A (en) | 1988-05-27 | 1992-04-21 | Mao Foundation For Medical Education And Research | Cytotoxic boronic acid peptide analogs |
| GB9017694D0 (en) | 1990-08-13 | 1990-09-26 | Sandoz Ltd | Improvements in or relating to organic chemistry |
| US5288707A (en) | 1990-08-13 | 1994-02-22 | Sandoz Ltd. | Borolysine peptidomimetics |
| GB9024129D0 (en) * | 1990-11-06 | 1990-12-19 | Thrombosis Research Trust | Inhibitors and substrates of thrombin |
| US5648338A (en) | 1990-11-06 | 1997-07-15 | Thrombosis Research Institute | Inhibitors and substrates of thrombin |
| AU2014892A (en) | 1991-04-30 | 1992-12-21 | Procter & Gamble Company, The | Liquid detergents with an aryl boronic acid |
| GB9224702D0 (en) | 1992-11-25 | 1993-01-13 | Thrombosis Res Inst | Boronic ester synthesis |
| FR2701951B1 (fr) | 1993-02-24 | 1995-06-09 | Adir | Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| NZ262415A (en) | 1993-03-03 | 1996-10-28 | Sandoz Ltd | Peptide boronic acid inhibitors having protease inhibiting activity |
| US5384410A (en) * | 1993-03-24 | 1995-01-24 | The Du Pont Merck Pharmaceutical Company | Removal of boronic acid protecting groups by transesterification |
| AU6448794A (en) * | 1993-03-24 | 1994-10-11 | Du Pont Merck Pharmaceutical Company, The | Boronic acid and ester inhibitors of thrombin |
| US5563127A (en) | 1993-03-24 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Boronic acid and ester inhibitors of thrombin |
| US5658885A (en) | 1993-04-27 | 1997-08-19 | The Dupont Merck Pharmaceutical Company | Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| IL109319A0 (en) | 1993-04-27 | 1994-07-31 | Du Pont Merck Pharma | Amidino and guanidino substituted boronic acid compounds |
| SE9900043D0 (sv) | 1999-01-11 | 1999-01-11 | Astra Ab | New use |
| US5681978A (en) * | 1993-07-07 | 1997-10-28 | Washington State University Research Foundation | Method for the stereocontrolled synthesis of stegobinone and useful borane intermediates |
| IL111176A0 (en) * | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them |
| AU7922794A (en) | 1993-10-07 | 1995-05-01 | Du Pont Merck Pharmaceutical Company, The | Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring |
| US5462964A (en) * | 1993-10-20 | 1995-10-31 | The Du Pont Merck Pharmaceutical Company | Dipeptide boronic acid inhibitors of trypsin-like enzymes |
| IL111175A0 (en) * | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
| US5431842A (en) | 1993-11-05 | 1995-07-11 | The Procter & Gamble Company | Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzyme |
| GB9401483D0 (en) | 1994-01-26 | 1994-03-23 | Sandoz Ltd | Organic compounds |
| FR2721611B1 (fr) | 1994-06-22 | 1996-09-27 | Adir | Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent . |
| US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| ATE252894T1 (de) | 1995-01-05 | 2003-11-15 | Univ Michigan | Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung |
| GB9502985D0 (en) | 1995-02-16 | 1995-04-05 | Thrombosis Res Inst | Enzyme inhibitors |
| GB9515489D0 (en) | 1995-07-28 | 1995-09-27 | Sandoz Ltd | Organic compounds |
| GB9613718D0 (en) * | 1996-06-29 | 1996-08-28 | Thrombosis Res Inst | Thrombin inhibitors |
| GB9724786D0 (en) * | 1997-11-25 | 1998-01-21 | Danbiosyst Uk | Oral delivery system |
| AU5788800A (en) | 1999-07-07 | 2001-01-22 | Du Pont Pharmaceuticals Company | Peptide boronic acid inhibitors of hepatitis c virus protease |
| SE9904483D0 (sv) | 1999-12-08 | 1999-12-08 | Astra Ab | New use |
| US6462021B1 (en) | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
| AU2002243646B2 (en) * | 2001-01-25 | 2006-06-22 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Formulation of boronic acid compounds |
| DE10133786A1 (de) | 2001-07-16 | 2003-02-06 | Boehringer Ingelheim Pharma | Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis |
-
2003
- 2003-09-09 JP JP2004569793A patent/JP2006509034A/ja active Pending
- 2003-09-09 MX MXPA05002661A patent/MXPA05002661A/es active IP Right Grant
- 2003-09-09 DK DK03255590T patent/DK1400245T3/da active
- 2003-09-09 CN CNB038214032A patent/CN100553639C/zh not_active Expired - Fee Related
- 2003-09-09 MX MXPA05002662A patent/MXPA05002662A/es not_active Application Discontinuation
- 2003-09-09 EP EP06113409A patent/EP1695711A3/en not_active Withdrawn
- 2003-09-09 CN CNB038213907A patent/CN100447151C/zh not_active Expired - Fee Related
- 2003-09-09 WO PCT/GB2003/003897 patent/WO2004022072A1/en active Application Filing
- 2003-09-09 AT AT03255590T patent/ATE324899T1/de not_active IP Right Cessation
- 2003-09-09 EP EP04076548A patent/EP1561466A3/en not_active Withdrawn
- 2003-09-09 KR KR1020057004076A patent/KR20050057294A/ko not_active Application Discontinuation
- 2003-09-09 NZ NZ539333A patent/NZ539333A/en unknown
- 2003-09-09 PT PT03255629T patent/PT1396270E/pt unknown
- 2003-09-09 EP EP03255604A patent/EP1396269A1/en not_active Withdrawn
- 2003-09-09 ES ES03255629T patent/ES2263924T3/es not_active Expired - Lifetime
- 2003-09-09 AU AU2003263328A patent/AU2003263328A1/en not_active Abandoned
- 2003-09-09 CA CA002536010A patent/CA2536010A1/en not_active Abandoned
- 2003-09-09 WO PCT/GB2003/003887 patent/WO2004022071A1/en active Application Filing
- 2003-09-09 AT AT04076510T patent/ATE376551T1/de not_active IP Right Cessation
- 2003-09-09 DK DK03255629T patent/DK1396270T3/da active
- 2003-09-09 AT AT03255629T patent/ATE325611T1/de not_active IP Right Cessation
- 2003-09-09 SI SI200330345T patent/SI1400245T1/sl unknown
- 2003-09-09 ES ES03255590T patent/ES2264515T3/es not_active Expired - Lifetime
- 2003-09-09 SI SI200330344T patent/SI1396270T1/sl unknown
- 2003-09-09 DE DE60304956T patent/DE60304956T2/de not_active Expired - Lifetime
- 2003-09-09 EP EP03255629A patent/EP1396270B1/en not_active Expired - Lifetime
- 2003-09-09 NZ NZ539334A patent/NZ539334A/en not_active IP Right Cessation
- 2003-09-09 KR KR1020057004077A patent/KR20050057295A/ko not_active Application Discontinuation
- 2003-09-09 JP JP2004569794A patent/JP2006503903A/ja active Pending
- 2003-09-09 PL PL376535A patent/PL376535A1/pl unknown
- 2003-09-09 WO PCT/GB2003/003883 patent/WO2004022070A1/en active Application Filing
- 2003-09-09 AU AU2003263333A patent/AU2003263333A1/en not_active Abandoned
- 2003-09-09 CA CA002535788A patent/CA2535788A1/en not_active Abandoned
- 2003-09-09 DE DE60317039T patent/DE60317039T2/de not_active Expired - Lifetime
- 2003-09-09 EP EP06113648A patent/EP1695712A3/en not_active Withdrawn
- 2003-09-09 EP EP03255590A patent/EP1400245B1/en not_active Expired - Lifetime
- 2003-09-09 JP JP2004569795A patent/JP2006511593A/ja active Pending
- 2003-09-09 EP EP04076510A patent/EP1466916B1/en not_active Expired - Lifetime
- 2003-09-09 BR BR0314450-0A patent/BR0314450A/pt not_active IP Right Cessation
- 2003-09-09 AU AU2003263343A patent/AU2003263343A1/en not_active Abandoned
- 2003-09-09 CA CA002535792A patent/CA2535792A1/en not_active Abandoned
- 2003-09-09 DE DE60305113T patent/DE60305113T2/de not_active Expired - Lifetime
- 2003-09-09 EP EP04076521A patent/EP1466917A1/en not_active Withdrawn
- 2003-09-09 PL PL03376439A patent/PL376439A1/xx unknown
-
2004
- 2004-08-09 HK HK04105939A patent/HK1063154A1/xx not_active IP Right Cessation
-
2005
- 2005-03-07 IL IL167294A patent/IL167294A/en not_active IP Right Cessation
-
2006
- 2006-07-03 CY CY20061100903T patent/CY1105381T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1400245T3 (da) | Borsyresalte anvendelige til parenterale formuleringer til selektiv thrombininhibering | |
| MXPA04012965A (es) | Inhibidores virales. | |
| WO2004032909A3 (en) | Stabilized pharmaceutical composition containing basic excipients | |
| FI942423A0 (fi) | Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| NO20042161L (no) | Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1 | |
| NO20051695L (no) | Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer | |
| AP2000001900A0 (en) | Halogeneted amidino amino acid derivatives useful as nitric oxide synthase inhibitors. | |
| ATE402175T1 (de) | 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| WO2002024697A1 (fr) | Composes spiro et inhibiteurs de molecules d'adhesion contenant ces composes comme ingredient actif | |
| WO2000040583A3 (de) | Imidazo[4,5-c]-pyridin-4-on-derivate | |
| WO2001081316A3 (en) | Substituted phenyl farnesyltransferase inhibitors | |
| SE9803773D0 (sv) | Compounds | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| SE0102057D0 (sv) | New Salts I | |
| DK0937043T3 (da) | Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater | |
| SE0102058D0 (sv) | New Salts II | |
| DE69828522D1 (de) | Antithrombotische mittel | |
| NO20022000L (no) | 6-metoksy-2-naftyleddiksyre-prodrogesammensetninger til behandling av inflammasjon | |
| AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
| SE0004827D0 (sv) | Therapeutic compounds | |
| WO2002018363A3 (en) | 3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors | |
| PT1220855E (pt) | Agentes terapeuticos | |
| DE60014915D1 (de) | Hypoxanthin- und thiohypxanthin-verbindungen |